Microvascular endothelial dysfunction in rheumatoid arthritis
- 31 May 2018
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Rheumatology
- Vol. 14 (7), 404-420
- https://doi.org/10.1038/s41584-018-0022-8
Abstract
The systemic autoimmune disease rheumatoid arthritis (RA) is characterized by increased cardiovascular mortality and morbidity and is an independent cardiovascular risk factor. Cardiovascular diseases (CVDs) result from accelerated atherogenesis, which is a consequence of endothelial dysfunction in the early stages of the disease. Endothelial dysfunction is a functional and reversible alteration of endothelial cells and leads to a shift in the properties of the endothelium towards reduced vasodilation, a pro-inflammatory state, and proliferative and prothrombotic properties. In RA, endothelial dysfunction can occur in the large vessels (such as the conduit arteries) and in the small vessels of the microvasculature, which supply oxygen and nutrients to the tissue and control inflammation, repair and fluid exchange with the surrounding tissues. Growing evidence suggests that microvascular endothelial dysfunction contributes to CVD development, as it precedes and predicts the development of conduit artery atherosclerosis and associated risk factors. As such, numerous studies have investigated microvascular endothelial dysfunction in RA, including its link with disease activity, disease duration and inflammation, the effect of treatments on endothelial function, and possible circulating biomarkers of microvascular endothelial dysfunction. Such findings could have important implications in the cardiovascular risk management of patients with RA.Keywords
This publication has 128 references indexed in Scilit:
- The Peroxisome Proliferator Activated Receptor‐γ Pioglitazone Improves Vascular Function and Decreases Disease Activity in Patients With Rheumatoid ArthritisJournal of the American Heart Association, 2013
- Anti-TNFα therapy transiently improves high density lipoprotein cholesterol levels and microvascular endothelial function in patients with rheumatoid arthritis: a Pilot StudyBMC Musculoskeletal Disorders, 2012
- Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studiesAnnals Of The Rheumatic Diseases, 2012
- Vascular Function and Handgrip Strength in Rheumatoid Arthritis PatientsThe Scientific World Journal, 2012
- Interleukin 17 as a novel predictor of vascular function in rheumatoid arthritisAnnals Of The Rheumatic Diseases, 2011
- Microvascular function is preserved in newly diagnosed rheumatoid arthritis and low systemic inflammatory activityClinical Rheumatology, 2011
- Relation of Brachial and Digital Measures of Vascular Function in the CommunityHypertension, 2011
- Lipoprotein(a) as a cardiovascular risk factor: current statusEuropean Heart Journal, 2010
- Cardiovascular Complications of Rheumatoid Arthritis: Assessment, Prevention, and TreatmentRheumatic Disease Clinics of North America, 2010
- Peripheral Arterial Tonometry for Risk Stratification in Men With Coronary Artery DiseaseClinical Cardiology, 2010